INFORSENSE LAUNCHES POWERFUL NEW BIOSCIENCE MODULE TO ENHANCE DRUG DISCOVERY PRODUCTIVITY (March 2004)
Streamlining Informatics for Genomics and Proteomics London, UK, March 10th 2004

InforSense Ltd., the leading provider of Open Discovery Workflow informatics platforms, launched today at the Drug Discovery Technology Conference, InforSense 1.9: BioScience, a new application module for analyzing genomics and proteomics data within the advanced InforSense Knowledge Discovery Environment (KDE) 1.9. Offering direct integration between sequences, expression data and ontology-based knowledge management for bioinformatics research, InforSense 1.9: BioScience provides a wealth of components for a wide range of analytical applications in genomics and proteomics study. Example application areas include integrative gene expression analysis and high throughput gene and protein annotation.

This latest addition to InforSense's powerful bioinformatics infrastructure means researchers now have direct access to, and can easily integrate, expression data management and analysis, sequence analysis and annotation, ontologies and other commonly used bioinformatics functions through InforSense workflows. Combined with an extensive range of generic data mining, statistical analysis and visualization tools within a flexible discovery informatics environment, scientists can now concentrate on their science rather than on the time-consuming integration of the necessary tools.

Moreover, within InforSense workflows, BioScience functions can be seamlessly integrated with cheminformatics and TextSense® text mining to create a unique platform to support informatics activities across the entire drug discovery process. With InforSense 1.9 as the informatics framework, researchers can easily build their own discovery informatics processes, rapidly integrating third-party or proprietary software, databases and web services. New applications can then be deployed to co-workers as web applications or services. Workflows can also be warehoused to create the process knowledge base of a discovery organization. "This new BioScience module extends the capabilities of our core infrastructure to work with genomic and proteomic data," commented Jonathan Sheldon, Chief Scientific Officer, Life Sciences at InforSense. "Combined with our existing cheminformatics capabilities, InforSense 1.9 represents a powerful framework for cross-discipline research that is today essential for enhanced drug discovery productivity." Images of InforSense 1.9: BioScience are available on request.

About InforSense

InforSense develops and markets next-generation discovery informatics platforms for individual researchers, cross-function teams and discovery enterprises based on its unique Open Discovery Workflow? technology. Using InforSense technology, individuals and organizations can exploit diverse information and software systems to create, integrate, manage and deliver valuable discovery knowledge and intellectual property within a single, integrated informatics environment. InforSense's unique value is based on the horizontal nature of its system enabling researchers to use the data they need, in whatever format, to drive their decision-making throughout the entire drug discovery research process from target discovery to drug development. InforSense customers include major pharmaceutical and biotechnology companies, as well as academic research institutions worldwide. For further information on InforSense products and solutions, visit www.inforsense.com